BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38010101)

  • 1. Is long-term follow-up solely by imaging tests safe in non-operated pancreatic neuroendocrine tumors?
    Polette D; Busquets J; Secanella Medayo L; Sorribas Grifell M; Peláez Serra N; Uribe C; Martinez-Carnicero L; Salord Vila S; Guerrero F; Vercher-Conejero JL; Teulé A; Fabregat J
    Rev Esp Enferm Dig; 2024 Apr; 116(4):209-215. PubMed ID: 38010101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Follow-up of Small Nonfunctioning Pancreatic Neuroendocrine Tumors Diagnosed Using Endoscopic Ultrasound-guided Fine-needle Aspiration.
    Takano Y; Yamawaki M; Noda J; Azami T; Niiya F; Maruoka N; Yamagami T; Norose T; Ohike N; Nagahama M
    Intern Med; 2023 Dec; 62(24):3585-3590. PubMed ID: 37081682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.
    Gaujoux S; Partelli S; Maire F; D'Onofrio M; Larroque B; Tamburrino D; Sauvanet A; Falconi M; Ruszniewski P
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4784-9. PubMed ID: 24057286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonfunctioning, small, incidental pancreatic neuroendocrine tumors: Results of a nonoperative approach cohort.
    Uribe Galeano C; Fabregat Prous J; Busquets Barenys J; Pelaez Serra N; Secanella Medayo L; Ramos Rubio E; Ruiz Osuna S; Villabona Artero C
    Cir Esp; 2017 Feb; 95(2):83-88. PubMed ID: 28162264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
    Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
    Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study.
    Zhu HB; Zhu HT; Jiang L; Nie P; Hu J; Tang W; Zhang XY; Li XT; Yao Q; Sun YS
    Eur Radiol; 2024 Jan; 34(1):90-102. PubMed ID: 37552258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.
    Kawasaki Y; Hijioka S; Nagashio Y; Maruki Y; Ohba A; Takeshita K; Takasaki T; Agarie D; Hagiwara Y; Hara H; Okamoto K; Yamashige D; Kondo S; Morizane C; Ueno H; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Tamada K; Hiraoka N; Saito Y; Okusaka T
    J Gastroenterol; 2023 Jul; 58(7):693-703. PubMed ID: 37154933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of small, asymptomatic, non-functioning pancreatic neuroendocrine tumours: follow-up, ablation, or surgery?
    Dąbkowski K; Starzyńska T
    Endokrynol Pol; 2023; 74(1):25-30. PubMed ID: 36519652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.
    Luo G; Liu Z; Guo M; Jin K; Xiao Z; Liu L; Liu C; Xu J; Ni Q; Long J; Yu X
    Pancreatology; 2015; 15(5):519-524. PubMed ID: 26365059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
    Sallinen V; Haglund C; Seppänen H
    Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
    de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
    Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
    Rosenberg AM; Friedmann P; Del Rivero J; Libutti SK; Laird AM
    Surgery; 2016 Jan; 159(1):302-9. PubMed ID: 26547726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis1.
    Yang D; Wang D; Qiu Y; Tian X; Zuo D; Dong Y; Lou W; Wang W
    Clin Hemorheol Microcirc; 2022; 80(4):343-352. PubMed ID: 34602462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study.
    Younis F; Ben-Ami Shor D; Lubezky N; Geva R; Osher E; Shibolet O; Phillips A; Scapa E
    Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1111-1115. PubMed ID: 36170679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Zhang IY; Zhao J; Fernandez-Del Castillo C; Braun Y; Razmdjou S; Warshaw AL; Lillemoe KD; Ferrone CR
    J Gastrointest Surg; 2016 Feb; 20(2):277-83. PubMed ID: 26691146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery or active surveillance for pNETs < 2 cm: Preliminary results from a single center Brazilian cohort.
    Arra DASM; Ribeiro HSC; Henklain G; Barbosa A; Torres SM; Diniz AL; Godoy AL; Farias IC; Costa WL; Coimbra FJF
    J Surg Oncol; 2022 Jul; 126(1):168-174. PubMed ID: 35689580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
    Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
    Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Heidsma CM; van Roessel S; van Dieren S; Engelsman AF; Strobel O; Buechler MW; Schimmack S; Perinel J; Adham M; Deshpande V; Kjaer J; Norlen O; Gill AJ; Samra JS; Mittal A; Hoogwater FJH; Primavesi F; Stättner S; Besselink MG; van Eijck CHJ; Nieveen van Dijkum EJM
    Neuroendocrinology; 2022; 112(6):571-579. PubMed ID: 34343138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors.
    Furukori M; Imai K; Karasaki H; Watanabe K; Oikawa K; Miyokawa N; Taniguchi M; Furukawa H
    World J Gastroenterol; 2014 Dec; 20(47):17949-54. PubMed ID: 25548493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.